Mantripragada Sankaram 4
4 · Rezolute, Inc. · Filed Sep 16, 2019
Insider Transaction Report
Form 4
Rezolute, Inc.RZLT
Mantripragada Sankaram
Chief Scientific Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2019-07-31+3,500,000→ 3,500,000 totalExercise: $0.29Exp: 2029-07-31→ Common Stock (3,500,000 underlying)
Footnotes (1)
- [F1]587,500 of the options is fully exercisable as of the date of grant. Vesting of 1,762,500 options will occur in thirty-six equal installments beginning on the first day of each month thereafter, such grant vested in full after 3 years. The remaining 1,150,000 options vest equally over a 36-month period following certain performance and market price criteria. Such remaining options will not necessarily vest or convert into non-derivative securities to be beneficially owned by the Reporting Person.